EUVIMEDEUVIMED entdecken
Open Access

Nuclear cholesterol regulates nuclear size and DNA damage responses in cancer stem cells

Tingting Duan, Suchet Taori, Shruti Bhargava, Sisi Lai, Cuiqing Zhong, Shira Yomtoubian, Huairui Yuan, Xujia Wu, Po Zhang, Tengfei Huang, Donghai Wang, Fanen Yuan und 13 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noaf110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Tingting Duan und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Cholesterol, Glioblastoma, DNA Damage. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, American Cancer Society Lisa Dean Moseley Foundation Cancer Stem Cell Consortium, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nuclear atypia is associated with increased malignancy in numerous cancers, including glioblastoma (GBM). Here, we found that GBM stem cells display small nuclear size, prompting investigation of mechanisms underlying nuclear size regulation in the tumor hierarchy.

Methods

We performed comparative gene expression and proteomics in GBM stem cells (GSCs) and neural stem cells (NSCs) to discover potential regulators of nuclear size. Through transcriptomic analysis, mass spectrometry, and pharmacologic inhibition, we interrogated the functional significance of nuclear size regulation.

Results

GSCs were enriched for a nuclear sterol reductase, lamin B receptor (LBR). Targeting LBR increased nuclear size and decreased GSC viability and tumor initiation. Regulation of nuclear cholesterol synthesis underlaid LBR dependency in GSCs. Loss of LBR or reduction of cholesterol levels induced double-strand DNA breaks (DSBs), activating P53-dependent DNA damage response (DDR). The GSC proteomic LBR interactome revealed DDR mediators, including DEAD-box RNA helicase DDX5 that resolves R-loops at DSBs. Genetic targeting of LBR reduced the DDX5-R loop interaction, leading to increased R-loop formation rescued by cholesterol supplementation. Pharmacological sterol reductase inhibition mirrored genetic LBR targeting by reducing the DDX5-R loop interaction and increasing R-loops and DSBs. Targeting LBR genetically and pharmacologically inhibits GSC growth in vivo and synergizes with irradiation.

Conclusions

Stem-like GBM cells display reduced nuclear size, driven by nuclear cholesterol synthesis to regulate radiation responses, revealing a novel therapeutic paradigm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsCholesterolGlioblastomaDNA DamageCell NucleusBrain NeoplasmsHumansAnimalsMiceTumor Cells, CulturedLamin B ReceptorReceptors, Cytoplasmic and Nuclear

Stichwörter der Autor:innen

cancer stem cellcholesterolglioblastomalamin B receptorradiation

Substanzen

CholesterolLamin B ReceptorReceptors, Cytoplasmic and Nuclear

Autor:innen und Institutionen

  • Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
  • Division of Regenerative Medicine, Department of Medicine, University of California at San Diego, San Diego, California, USA.
  • Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Altos Labs, Inc., San Diego, California, USA.

ORCID-Profile: Marlies Meisel, Jeremy N Rich

Förderung

  • NCI NIH HHS
  • American Cancer Society Lisa Dean Moseley Foundation Cancer Stem Cell Consortium
  • NIH HHS
  • Defense Health Agency
  • University of Pittsburgh Flow Cytometry Lab and the University of Pittsburgh Biospecimen Core
  • National Institutes of Health

Zitieren

APA

Duan, T., Taori, S., Bhargava, S., Lai, S., Zhong, C., Yomtoubian, S., Yuan, H., Wu, X., Zhang, P., Huang, T., Wang, D., Yuan, F., Li, D., Li, H., Mi, H., Wu, W., Wang, R., Habib, A., Hammed, F., …, & Rich, J. N. (2025). Nuclear cholesterol regulates nuclear size and DNA damage responses in cancer stem cells. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf110

Vancouver

Duan T, Taori S, Bhargava S, Lai S, Zhong C, Yomtoubian S, et al. Nuclear cholesterol regulates nuclear size and DNA damage responses in cancer stem cells. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf110

BibTeX
@article{Duan2025,
  author = {Duan, Tingting and Taori, Suchet and Bhargava, Shruti and Lai, Sisi and Zhong, Cuiqing and Yomtoubian, Shira and Yuan, Huairui and Wu, Xujia and Zhang, Po and Huang, Tengfei and Wang, Donghai and Yuan, Fanen and Li, Daqi and Li, Huan and Mi, Hailong and Wu, Weichi and Wang, Rui and Habib, Ahmed and Hammed, Farrukh and Vendetti, Frank P and Zinn, Pascal O and Bakkenist, Christopher J and Meisel, Marlies and Wu, Qiulian and Rich, Jeremy N},
  title = {Nuclear cholesterol regulates nuclear size and DNA damage responses in cancer stem cells},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noaf110}
}
Kostenlos starten →